Focus
Pfizer BioNTech
LATEST
No Clinical Data in Health Canada’s ‘Thorough’ Review of Latest Pfizer COVID Shot
Health Canada says the safety and effectiveness of Pfizer’s XBB.1.5 shot is inferred from studies conducted on its previous mRNA products.
|
70 Percent of Deaths from Pfizer Vaccine in Japan Reported Within 10 Days of Jab: Study
Number of deaths within the first 10 days of vaccination was ’significantly higher' than those between 11 and 180 days among people aged 64 and under.
|
|
|
No Clinical Data in Health Canada’s ‘Thorough’ Review of Latest Pfizer COVID Shot
Health Canada says the safety and effectiveness of Pfizer’s XBB.1.5 shot is inferred from studies conducted on its previous mRNA products.
|
70 Percent of Deaths from Pfizer Vaccine in Japan Reported Within 10 Days of Jab: Study
Number of deaths within the first 10 days of vaccination was ’significantly higher' than those between 11 and 180 days among people aged 64 and under.
|
|
|